Overall progress from 2009 to 2022
As a result of compliance check, testing proposal examination and substance evaluation, since 2009, ECHA issued more than 3 790 decisions covering approximately 12 200 information requests on more than 2 600 substances.
An analysis for 2020-2022 revealed that around 20 % of completed dossier evaluation cases were being considered for further regulatory action (harmonised classification and labelling (CLH), endocrine disruptor (ED), and persistent, bioaccumulative and toxic (PBT) assessment or substance evaluation). The most frequent outcome by far was the consideration of a CLH process, particularly for reproductive toxicity concerns.
Evaluation progress, 2009-2022
| Evaluation process |
Adopted decisions |
Information requests |
Information requests by area |
Annex I
(incl. CSR, RSS, PBT)* |
Annex VI
(incl. SID, C&L)* |
Physico-chemical |
Environment |
Human Health |
| Compliance check |
2 130 |
8 669 |
431 |
579 |
292 |
3 629 |
3 738 |
| Testing proposal examination |
1 472 |
2 834 |
N/A |
N/A |
164 |
885 |
1 785 |
| Substance evaluation ** |
194 |
699 |
261 |
22 |
45 |
161 |
210 |
| TOTAL |
3 796 |
12 202 |
692 |
601 |
501 |
4 675 |
5 733 |
* Annex I: General provisions for assessing substances and preparing chemical safety reports (CSR); Annex VI: Information requirements referred to in Article 10 (information to be submitted for general registration purposes); CSR: chemical safety report; RSS: robust study summary; PBT: persistent, bioaccumulative and toxic; SID: substance identification; C&L: classification and labelling.
** The substance evaluation process started in 2012.
